Oxford BioDynamics PLC (OBD)

Industry Diagnostics & Research

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

0.18p

Buy

0.20p

arrow-down-0.01p (-5.00%)

Prices updated at 02 Apr 2026, 16:16 BST

Prices minimum 15 mins delay

Prices in GBX

Oxford BioDynamics PLC is a biotechnology company. It is focused on the discovery and development of novel epigenetic biomarkers for use within the pharmaceutical and biotechnology industry.

FTSE All-Share

0.59%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

Mr. Iain Gladstone Ross

CEO

-

Most recent earnings

30 Sep 2025

Fiscal year end

30 Sep 2025

Employees

51

Head office

John Smith Drive

Oxford

United Kingdom

OX4 2WB

+44 1865518910

investorrelations@oxfordbiodynamics.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Dr. David Mark Anthony Holbrook Non-Executive Director	-
Mr. Peter Eric Presland Non-Executive Director	-
Dr. Alexandre Akoulitchev Executive Director, Chief Scientific Officer	-
Mr. Paul Leslie Stockdale Executive Director, Chief Financial Officer	-
Mr. Iain Gladstone Ross Executive Director, Chairman	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Unicorn Asset Management Ltd	278,464,859
Unicorn AIM VCT Series 3 ORD	278,464,859
Crux Asset Management Limited	116,911,962
TM Oberon UK Smaller Companies Fund	116,911,962
Zeus Investment Management Limited	60,000,000

Director dealings

Date chevron-l-regular chevron-r-regular	Action
11 Nov 2025	Purchase
11 Nov 2025	Purchase
11 Nov 2025	Purchase
11 Nov 2025	Purchase
11 Nov 2025	Purchase
10 Apr 2025	Purchase

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.